Page last updated: 2024-08-24

adenosine and Non-ST Elevated Myocardial Infarction

adenosine has been researched along with Non-ST Elevated Myocardial Infarction in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Adriaans, BP; Bekkers, SCAM; Bijvoet, GP; Crijns, HJGM; Gerretsen, SC; Heijman, J; Kim, RJ; Mingels, AMA; Schalla, S; Smulders, MW; Theunissen, RALJ; van Cauteren, YJM; van Kuijk, SMJ; Wildberger, JE1
Cho, JY; Cho, SA; Hong, SJ; Jeong, HS; Joo, HJ; Kim, JH; Lee, SH; Lim, DS; Park, JH; Yu, CW1
Adamska, U; Adamski, P; Buszko, K; Gorog, DA; Kubica, A; Kubica, J; Laskowska, E; Marszałł, MP; Navarese, EP; Ostrowska, M; Paciorek, P; Rość, D; Sikora, A; Sikora, J; Skibińska, N; Sobczak, P; Umińska, JM1
Carugo, S; Castini, D; Cazzaniga, S; Centola, M; Ferrante, G; Lucreziotti, S; Persampieri, S; Salerno-Uriarte, D; Sponzilli, C1
Dong, C; Liu, X; Ren, C; Ren, Q; Zhang, X1
Cheema, AN; Cieza, T; Dehghani, P; Déry, JP; Fisher, HN; Goodman, SG; Henderson, MA; Kokis, A; Lavi, S; Lutchmedial, S; Mehta, SR; Siega, AJ; Welsh, RC; Wong, BY; Zhang, X; Zhu, YE1
Holm, M; Rihan Hye, S; Tornvall, P; van der Linden, J; Westerberg, J1
Andolina, G; Carella, M; Castellana, C; Coppola, G; Corrado, E; Evola, S; Novo, G; Novo, S; Raso, S; Sucato, V1

Trials

3 trial(s) available for adenosine and Non-ST Elevated Myocardial Infarction

ArticleYear
Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2021, 03-22, Volume: 23, Issue:1

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Coronary Artery Disease; Coronary Stenosis; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Non-ST Elevated Myocardial Infarction; Predictive Value of Tests; Reproducibility of Results; Vasodilator Agents

2021
Comparison of Ticagrelor Versus Prasugrel for Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Requiring Coronary Stenting: A Prospective, Randomized,
    JACC. Cardiovascular interventions, 2017, 08-28, Volume: 10, Issue:16

    Topics: Acute Coronary Syndrome; Adenosine; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelial Progenitor Cells; Female; Humans; Inflammation Mediators; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Seoul; Stents; Ticagrelor; Time Factors; Treatment Outcome; Vasodilation

2017
Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose.
    Platelets, 2017, Volume: 28, Issue:7

    Topics: Adenosine; Adenosine Diphosphate; Aged; Biotransformation; Blood Platelets; Coronary Artery Disease; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Sweden; Ticagrelor

2017

Other Studies

5 other study(ies) available for adenosine and Non-ST Elevated Myocardial Infarction

ArticleYear
Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Adenosine; Aged; Biological Availability; Blood Platelets; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor

2017
Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience.
    Therapeutic advances in cardiovascular disease, 2017, Volume: 11, Issue:12

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Hemorrhage; Hospital Mortality; Humans; Italy; Logistic Models; Male; Middle Aged; Multivariate Analysis; Non-ST Elevated Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome

2017
Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromes.
    Herz, 2016, Volume: 41, Issue:3

    Topics: Acute Coronary Syndrome; Adenosine; Bradycardia; Clopidogrel; Comorbidity; Electrocardiography; Female; Germany; Humans; Male; Non-ST Elevated Myocardial Infarction; Prevalence; Purinergic P2Y Receptor Antagonists; Risk Factors; Survival Rate; Ticagrelor; Ticlopidine; Treatment Outcome

2016
Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (C
    American heart journal, 2016, Volume: 181

    Topics: Adenosine; Adult; Aged; Aged, 80 and over; Canada; Clopidogrel; Drug Substitution; Emergency Medical Services; Emergency Service, Hospital; Female; Hemorrhage; Hospitalization; Humans; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Young Adult

2016
Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2017, Volume: 18, Issue:6

    Topics: Adenosine; Aged; Female; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Ticagrelor; Treatment Outcome

2017